Logo
Search
Home
Podcasts
Archives
Tags
Logo

EMA

AI

+3

The AI everyone discusses in drug development is the AI regulators have barely reviewed

Jun 4, 2026

•

4 min read

The AI everyone discusses in drug development is the AI regulators have barely reviewed

The constraint is not model quality. It is a missing track record, and that is an application-layer problem

Szczepan Baran
Szczepan Baran

FDA

+3

THE DIGITAL RECORD

May 14, 2026

•

11 min read

THE DIGITAL RECORD

Issue #1 · Thursday, May 14, 2026

Szczepan Baran
Stefano Gaburro
Szczepan Baran, +1

Digital Record

The weekly newsletter of the Digital Preclinical Society. Application-first coverage of the regulatory shifts, methods, and decisions reshaping preclinical drug development. Free, weekly.


© 2026 Digital Preclinical Society